ANDARINE - Spectre Labs

Andarine, known in research circles as S4, represents a second-generation SARM aimed at minimizing muscle loss while promoting fat reduction. Developed by GTx Inc., it was intended for treating conditions like muscle wasting and benign prostatic hypertrophy. Unlike traditional anabolic steroids, Andarine’s selective mechanism reduces the risk of prostate enlargement while maintaining anabolic effects in muscle and bone. Although clinical trials were halted, it remains a popular option among bodybuilders seeking a lean, dry look without the significant androgenic effects associated with steroids.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about ANDARINE by Spectre Labs, consult with your doctor or healthcare professional.